Global Tobacco Control Policy Debate: Medical Experts Call for Science-Based Approach, Promoting Harm Reduction Over Total Bans

Sep.09.2025
Health professionals worldwide are urging a shift from abstinence-only tobacco policies toward evidence-based harm reduction. Despite bans, smoking remains prevalent in countries like India, while prohibition fuels black markets in Europe and misinformation among doctors in the U.S. Many argue that regulated alternatives could save lives where cessation fails.

Key Points:

 

·Smoking causes millions of preventable deaths yearly, yet harm reduction is often ignored.

·India’s vaping ban failed to reduce smoking; instead, illicit markets grew.

·Doctors in India, the U.S., and Europe are advocating for regulated smoke-free alternatives.

·Many U.S. physicians are misinformed—most don’t know nicotine isn’t the primary cause of cancer.

·Prohibition enables youth access via black markets and social media, as seen in the Netherlands.

·Experts emphasize: quitting is best, but safer alternatives should be available for those who can’t quit.

 


 

2Firsts, September 9th - according to vaping post reported in September 8th, for over a century, smoking has been a major cause of preventable death globally. It kills more than a million people each year in India, nearly half a million in the U.S., and in Europe, youth nicotine use is increasingly linked to black markets and online loopholes. Despite the severe toll, many governments remain skeptical of harm reduction or ignore it entirely. Now, more health professionals are urging policies grounded in science and compassion.

 

India’s experience highlights the consequences. Despite a 2019 ban on e-cigarettes, smoking rates remain high, with over 253 million Indians using tobacco—often in dangerous forms like bidis and gutkha. Instead of reducing demand, the ban fueled a black market for unregulated products.

 

Some doctors are challenging this approach. Vaibhav Sahni and Abhishek Shankar from AIIMS argued that regulated e-cigarettes could help smokers transition away from combustible tobacco and should be part of a harm reduction strategy. Their institution quickly distanced itself from the view, but the debate reflects a growing shift toward evidence-based policy.

 

Other countries offer alternative models. The UK, for example, promotes regulated smoke-free alternatives for adults while protecting youth. Such frameworks acknowledge that while quitting is best, safer options should exist for those who can’t or won’t stop.

 

In the U.S., a survey of healthcare providers found that 93% believe the FDA should share information about less harmful smoke-free products. Yet, most doctors remain unaware of authorized alternatives, and many mistakenly believe nicotine causes cancer. In fact, most harm comes from combustion, not nicotine. This misinformation reinforces an unrealistic “quit or die” approach.

 

In Europe, prohibition has also led to unintended outcomes. Following a ban on flavored vapes in the Netherlands, illegal products with high nicotine levels flooded the market. Doctors report rising youth vaping, fueled by social media and underground sales.

 

Across regions, prohibition often creates black markets, leaves doctors misinformed, and limits choices for smokers. Many health experts are now calling for pragmatic harm reduction: policies that recognize different levels of risk, educate clinicians, and provide adults with safer alternatives.

 

The best option will always be to quit entirely. But for those who can’t, having no safer alternative isn’t protection—it’s a failure of public health. Governments should empower doctors with accurate information, support responsible regulation, and move beyond the false choice between quitting and continuing to smoke.
 

France’s Top Administrative Court Suspends Nicotine Pouch Decree
France’s Top Administrative Court Suspends Nicotine Pouch Decree
France’s Council of State has suspended a government decree that was set to ban the manufacture, production and export of nicotine pouches from April 2026. The court ruled that companies were not given sufficient time to reorganise their operations. A final decision on the legality of the decree is expected by June 2026. The court noted that the commercial sale of nicotine pouches is already restricted under existing public health laws.
Dec.23 by 2FIRSTS.ai
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Exclusive: Altria Confirms FDA Grants Marketing Authorization to on! PLUS, Ending More Than a Year of PMTA Review
Altria on December 19 confirmed that six on! PLUS nicotine pouch products had received U.S. FDA marketing authorization, ending a PMTA review lasting more than a year after the company moved ahead with launch plans before clearance.
Regulations
Dec.20
Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates
Sweden on Track to Become Europe’s First Smoke-Free Nation as Snus and Nicotine Pouches Support Declining Smoking Rates
According to Gulf News, Sweden is nearing the World Health Organization’s smoke-free threshold, with daily smoking falling below 5%. Two decades of public health efforts and the growing use of lower-risk alternatives such as Snus and tobacco-free nicotine pouches have contributed to this shift, alongside declines in tobacco-related deaths and lung cancer cases.
Dec.04 by 2FIRSTS.ai
Turkey Plans to Ban E-Cigarette Advertising Under Revised Commercial Advertising Rules
Turkey Plans to Ban E-Cigarette Advertising Under Revised Commercial Advertising Rules
Turkey is advancing amendments to its Regulation on Commercial Advertising and Unfair Commercial Practices, proposing stricter controls on e-cigarette and gambling advertising.
Dec.26 by 2FIRSTS.ai
Belarus to Tighten Vape Regulations, Raise Excise Taxes in 2026
Belarus to Tighten Vape Regulations, Raise Excise Taxes in 2026
Belarusian lawmakers are drafting a new bill to regulate the vape market amid growing concern over youth nicotine use and the spread of illegal products. While a total ban is not planned, the focus will be on stricter licensing, advertising limits, and higher taxes.
Nov.19 by 2FIRSTS.ai
Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes
Philip Morris Japan launches new IQOS SENTIA “Icy Red” flavor with icy menthol and red berry notes
Philip Morris Japan has announced the launch of a new SENTIA Icy Red tobacco stick for its IQOS ILUMA i and IQOS ILUMA heated tobacco devices, featuring an intense menthol profile with red fruit notes. The new product will roll out in stages from December across physical IQOS outlets, online channels and tobacco retailers nationwide in Japan, priced at 530 yen (approx. USD 3.4) per pack.
Dec.01 by 2FIRSTS.ai